Related references
Note: Only part of the references are listed.Serum chemerin and vaspin in non-alcoholic fatty liver disease
Michal Kukla et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)
M. Yoneda et al.
DIGESTIVE AND LIVER DISEASE (2008)
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
S. A. Harrison et al.
GUT (2008)
A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients
Guilherme M. Campos et al.
HEPATOLOGY (2008)
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver fibrosis panel and exploring simple markers
Indra Neil Guha et al.
HEPATOLOGY (2008)
The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosis
Bulent Degertekin et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
Anna Wieckowska et al.
HEPATOLOGY (2006)
Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease
A Suzuki et al.
LIVER INTERNATIONAL (2005)
Steatohepatitis in obese individuals
WI Youssef et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2002)
The utility of radiological imaging in nonalcoholic fatty liver disease
S Saadeh et al.
GASTROENTEROLOGY (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
JB Dixon et al.
GASTROENTEROLOGY (2001)
Liver fibrosis in overweight patients
V Ratziu et al.
GASTROENTEROLOGY (2000)
Share Paper
